Abstract. Extracellular ATP is now recognized as a neurotransmitter or neuromodilator in the nervous system, producing diverse physiological effects by activating multiple P2 receptors. Although P2-receptor signaling is terminated by hydrolysis of ATP by the ecto-nucleotidase cascade, such a metabolic step leads to adenosine generation, thereby initiating adenosine (P1)-receptor activation. Because most cells and tissues co-express P1 and P2 receptors, ecto-nucleotidase on target tissues, especially enzymes catalyzing adenosine formation, are determinants of the cellular response to ATP. Ecto-5'-nucleotidase (E-5'-NT) has been considered to play a principal role in conversion of AMP to adenosine. In addition to E-5'-NT, we have recently demonstrated that ecto-alkaline phosphatase is also involved in ATP-induced P1-receptor activation through a rapid and localized adenosine production on the membrane surface. In this minireview, we describe the pharmacological profile of ecto-nucleotidase-dependent P1-receptor activation by ATP and molecular bases of preferential delivery of metabolically generated adenosine to P1 receptors. Several lines of evidence suggest that the close association between ecto-nucleotidases and P1 receptors may constitute a functional receptor for extracellular ATP, and some physiological responses to ATP would occur through this mechanism.
Introduction
Extracellular adenosine and adenine nucleotides induce various cellular responses through activation of P1 and P2 receptors. P1 receptors preferentially recognize adenosine and four different G protein-coupled receptors (A 1 , A 2A , A 2B , and A 3 subtypes) are identified (1) . On the other hand, P2 receptors are activated by adenine and / or uridine nucleotides and classified into two families: ionotropic P2X and G protein-coupled P2Y receptors (2) . Since P1-and P2-receptor classification was established, considerable efforts have been directed toward identifying receptors that mediate ATP-induced physiological responses. For this purpose, researchers have tried to distinguish the P2 receptormediated effect from the P1 receptor-mediated one using various pharmacological and biochemical tools, including metabolically stable P2-receptor agonists, P1-and P2-receptor antagonists, adenosine deaminase (ADA), and adenosine uptake inhibitors.
Despite such efforts, pharmacological profiles of the adenine nucleotide-induced response in many tissues, especially in the central (3, 4) and peripheral nervous system (5 -7), are diverse; and the actions of adenine nucleotides did not easily fit to P2X or P2Y receptormediated actions. In those studies, the possible involvement of metabolically generated adenosine was excluded by demonstrating that the responses were not inhibited by ADA (3 -5) or were not augmented by adenosine uptake inhibitors (6, 7) . In addition, metabolically stable ATP analogues, such as b,g-methylene ATP (b,g-MeATP), were as potent as ATP (6, 7) . These studies led to a proposal of novel purinoceptors termed P3 (7) or ATP-sensitive P1 receptor (8) .
Previously, we found that ATP-induced cyclic AMP accumulation in NG108-15 cells had pharmacological profiles that were similar to the P3 or ATP-sensitive P1 receptor (9) . However, detailed analysis combined with measurement of extracellular ATP catabolism revealed that ATP indirectly activates adenosine receptors through a rapid and localized adenosine formation (10 -12) . In this review, we are going to address the potential role of ecto-nucleotidase in the ATP-induced response, which has an atypical pharmacological profile. ] i increase is dependent on Ca 2+ influx through the P2X 7 receptor (14 -17) .
ATP-induced responses
In contrast to the Ca 2+ response, ATP-induced cyclic AMP accumulation exhibited a unique pharmacological profile different from any molecularly defined P2-receptor (9, 10, 18) . These include the following characteristics: 1) the ATP-induced response was inhibited by a P1-receptor antagonist, such as xanthine amine congener and 8-(p-sulfophenyl)theophylline, while it was resistant to ADA; 2) it was mimicked by metabolically stable ATP analogues, such as b,g-MeATP and adenosine 5'-O-(3-thiotriphosphate), whereas typical P2-receptor agonists, including a ,b-methylene ATP (a ,b-MeATP), 2-methylthio ATP, and UTP, were all ineffective; 3) it was inhibited by non-selective P2-receptor antagonists, such as pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS) and reactive blue 2; and 4) it was not affected by the adenosine uptake inhibitor nitrobenzyl thioinosine or the ecto-5'-nucleotidase (E-5'-NT) inhibitor a ,b-MeADP. Parent cell lines of NG108-15 cells, C6-Bu-1, but not N18TG-2 cells, showed similar ATP-induced cyclic AMP accumulation (12, 19) . Since N18TG-2 cells possess functional A 2A and A 2B receptors (19) , direct activation of P1 receptors by ATP or ATP analogues was ruled out. These results let us suggest the existence of a novel adenylyl cyclase-linked nucleotide receptor in NG108-15 cells, which may be relevant to the P3 (7) or the nucleotide-sensitive P1 receptors (8) . However, comparison of cyclic AMP responses between NG108-15 and C6 Bu-1 cells revealed a critical difference that is against the existence of novel receptors.
Role of ecto-nucleotidases in ATP-induced adenosine receptor activation
Although the pharmacological profile of ATPinduced cyclic AMP accumulation in C6Bu-1 cells were similar to those in NG108-15 cells with respect to agonist and antagonist sensitivities and to the ADA resistance, the ATP-induced cyclic AMP response in C6Bu-1 cells was totally inhibited by the E-5'-NT inhibitor a,b-MeADP, which had no effect in NG108-15 cells (19) . These results rather indicated that ATPinduced cyclic AMP formation in C6Bu-1 is dependent on adenosine generation. Analyses of extracellular adenine nucleotide metabolism revealed that pharmacological and biochemical tools used in NG108-15 cells to distinguish from adenosine-mediated effects did not produce their expected effects (11, 12) . Thus, a,bMeADP failed to block the adenosine formation from ATP, but the P2-receptor antagonist PPADS potently inhibited adenosine formation from ATP. In addition, adenosine was produced even from the metabolically stable ATP analogue. It is therefore suggested that ATP-induced cyclic AMP response in NG108-15 cells also depends on the adenosine formation and NG108-15 cells possess an adenosine generating enzyme other than E-5'-NT.
Ecto-alkaline phosphatase as adenosine generating enzyme
Extracellular nucleotide metabolism is mediated by a cascade of membrane-bound enzymes (20) . The currently known ecto-nucleotidases are ecto-nucleoside triphosphate diphosphohydrolases (NTPDases), ectopyrophosphatase / phosphodiesterases (NPPs), E-5'-NT (CD73) and ecto-alkaline phosphatase (ALP) ( Table 1) . Among the NTPDase family, NTPDase1 -3 are plasma membrane bound enzymes. NTPDase1 (ecto-apyrase, CD39) hydrolyzes ATP and ADP with similar rates, whereas NTPDase2 (ecto-ATPase or CD39L1) hydrolyzes ATP with high selectivity over ADP. NTPDase3 (CD39L3 or HB6) hydrolyzes ATP with some selectivity over ADP. Other NTPDase members (NTPDase4 -6) are less selective for adenine nucleotides and located in intracellular organelles, such as the Golgi apparatus (NTPDase4), or secreted as soluble enzymes (NTPDase5, 6). The E-NPP family is composed of NPP1 (PC-1); NPP2 (autotaxin or PD-Ia , recently identified as lysophopholipase D (21) to hydrolyze lysophosphatidylcholine into lysophosphatidic acid); and NPP3 (gp130 , B10, or PD-Ib). These enzymes hydrolyze ATP directly to AMP. E-5'-NT has been considered to plays a principal role in conversion of AMP into adenosine. Ecto-ALP is also able to hydrolyze AMP to adenosine, but less attention has been paid to the role of ALP in the ATP-induced response and extracellular nucleotide metabolism.
Analyses of ecto-nucleotidase gene transcripts in NG108-15, C6Bu-1, and N18TG-2 cells revealed that these cells commonly expresses NPP1 as the ATP hydrolyzing enzyme (12) . In contrast, there was a marked difference in distribution of adenosine generating enzymes. Namely, NG108-15 cells highly express the tissue nonspecific isoform of ALP (10), while C6Bu-1 express E-5'-NT (12) . In addition, N18TG-2 cells had no adenosine generating enzyme (12) , which was consistent with the lack of ATP-induced cyclic AMP accumulation in N18TG-2 cells. The presence of NPP1 accounts for the hydrolysis of b,g-MeATP and ATPgS. We confirmed that an ALP inhibitor, such as levamisole, inhibited ATP-induced cyclic AMP accumulation as well as adenosine generation from ATP in NG108-15 cells (10). Furthermore, PPADS was found to be a potent inhibitor of NPP1 and ALP (10) . It is also important to note that difference in the adenosine generating enzyme expressed in NG108-15, N18TG-2, and C6Bu-1 cells brings about the diverse pharmacological profile of the ATP-induced response. Since ALP is distributed in a wide variety of cell types, these observations indicate that ALP plays an important role in extracellular ATP metabolism as similar to E-5'-NT.
Rapid and localized adenosine generation on membrane surface
The ATP-induced response via adenosine receptor activation was very similar to the adenosine-induced one with respect to the time course, the maximal response, and the effective concentration range of the agonists (9, 22) , implying that adenine nucleotides are immediately and totally hydrolyzed to adenosine on the membrane surface. Critical role of local adenosine formation in the ATP-induced response has been suggested in the rat hippocampus (23, 24) and frog neuromuscular junction (25) . In those studies, ATP was supposed to undergo rapid hydrolysis to adenosine within <1 s and subsequently inhibit neurotransmission via the A 1 receptor. Recently, definitive evidence for this idea has been demonstrated in mice lacking the A 1 receptor (26). However, these studies did not directly demonstrate the localized adenosine formation on the membrane surface.
Using [
3 H]AMP as a substrate, we demonstrated a rapid increase in [
3 H]adenosine level on the membrane surface even in the presence of ADA (11, 12, 22) . In addition, brief treatment with an excess amount of ATP or b,gMeATP markedly reduced the following [
3 H]adenosine accumulation by [ 3 H]AMP hydrolysis, suggesting that hydrolysis of ATP or b ,g-MeATP would occur in the same environment on the membrane (22) . Both CD73 and ALP are glycosylphosphatidilinositol-anchored proteins and are known to localize in the caveolae (27) , a specialized microdomain of the plasma membrane, which has been proposed to play a role in diverse cellular signaling processes, including adenylyl cyclaselinked signal transduction system (28). Furthermore, Lasley et al. (29) have recently shown that A 1 receptors are also localized in the caveolae. On the basis of these observations, we hypothesized that adenosine generating enzymes are co-localized with adenosine receptors on the membrane surface, where adenosine converted from AMP can efficiently stimulate adenosine receptors.
Physiological significance of functional coupling of ecto-nucleotidase and P1 receptors
Functional significance of ecto-nucleotidase in extracellular ATP signaling is illustrated in Fig. 1 . Extracellular adenosine concentration is estimated to be in the submicromolar range, which is enough to stimulate high affinity adenosine receptor subtypes, such as A 1 and A 2A receptors (2) . However, the actual adenosine concentration in the receptor environment may be maintained at much lower level by an active uptake through adenosine transporter and conversion to inosine by ecto-ADA, which is known to co-localize with A 1 and A 2B receptors (30) . In addition, adenosine release under the physiological state is obscure, while it is markedly accumulated in the extracellular space under pathophysiological conditions, such as inflammation and is- chemia. In contrast, ATP is actively released into the extracellular space under physiological conditions through several different mechanisms. Since adenosine transporter or ADA does not target ATP even after conversion into AMP, ATP can distribute to the adenosine-receptor site efficiently as a pro-agonist. Therefore, the close association of ecto-nucleotidase to adenosine receptors may function as an ATP-receptor system, and E-5'-NT and ALP may be a determinant of the cellular response to ATP. Recently, such locally regulated ATP response has been demonstrated in the nucleus tractus solitarii where ATP inhibits evoked glutamate release from the primary afferent terminals via presynaptic adenosine A 1 receptors after conversion to adenosine, whereas it facilitates spontaneous release of glutamate from the axon terminals via P2X receptors (31) .
Conclusions
In a series of our recent work, we describe the role of ecto-nucleotidase in the ATP-induced response. These enzymes also play a critical role in P2-receptor signaling to terminate receptor activation. Since each ecto-nucleotidase largely affects the cell response to extracellular ATP, analysis of the expression pattern of individual ecto-nucleotidases in specific cell types would be very important. Currently, no specific high-affinity inhibitors of ecto-nucleotidases are available. Development of such inhibitors for individual ecto-nucleotidases would lead to great progress in our knowledge of ecto-nucleotidase function. signaling. In a microdomain, ATP receives progressive hydrolysis to AMP, but delivered to the adenosine receptor site without being affected by ADA or adenosine transporter, and acts as pro-agonist for the adenosine receptors. Hydrolysis of AMP to adenosine near the receptor site effectively activates the adenosine receptor. Shadow shows the gradient of adenosine concentrations. AC, adenylyl cyclase; Gi, inhibitory G protein; Gs, stimulatory G protein.
